These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15662534)

  • 1. [Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy].
    Seybold H; Simon M; Schuler G; Lüftl M
    Hautarzt; 2006 Jan; 57(1):47-50. PubMed ID: 15662534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin for recurrent cutaneous necrotizing eosinophilic vasculitis.
    Tanglertsampan C; Tantikun N; Noppakun N; Pinyopornpanit V
    J Med Assoc Thai; 2007 Jun; 90(6):1180-2. PubMed ID: 17624214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous vasculitis in Behçet's disease: a clinical and histopathologic study of 20 patients.
    Chen KR; Kawahara Y; Miyakawa S; Nishikawa T
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):689-96. PubMed ID: 9146529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous small-vessel vasculitis.
    Lotti T; Ghersetich I; Comacchi C; Jorizzo JL
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):667-87; quiz 688-90. PubMed ID: 9810883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing polychondritis and erythema elevatum diutinum: an unusual association refractory to dapsone.
    Delgado J; Gómez-Cerezo J; Sigüenza M; Barbado FJ; Dupond JL; Vazquez JJ
    J Rheumatol; 2001 Mar; 28(3):634-5. PubMed ID: 11296973
    [No Abstract]   [Full Text] [Related]  

  • 6. Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa.
    Dewar CL; Bellamy N
    J Rheumatol; 1992 Aug; 19(8):1308-11. PubMed ID: 1357171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis.
    Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A
    Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
    Ko JH; Shih YC; Hui RC; Yang CH
    J Clin Oncol; 2011 Mar; 29(7):e169-70. PubMed ID: 21149656
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous necrotizing vasculitis associated with hepatitis A virus infection.
    Press J; Maslovitz S; Avinoach I
    J Rheumatol; 1997 May; 24(5):965-7. PubMed ID: 9150090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G4-related disease associated with cutaneous vasculitis.
    Kawakami T; Yamaguchi N; Soma Y; Yokoyama K; Shirai S; Kimura K
    Acta Derm Venereol; 2014 May; 94(3):327-8. PubMed ID: 24096856
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of refractory cutaneous lupus vasculitis with i.v. immunoglobulin.
    Takamuki R; Okiyama N; Inoue S; Endo R; Kondo Y; Chino Y; Sumida T; Fujimoto M
    J Dermatol; 2019 Jul; 46(7):e253-e255. PubMed ID: 30714643
    [No Abstract]   [Full Text] [Related]  

  • 12. Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
    Micheletti RG; Pagnoux C; Tamura RN; Grayson PC; McAlear CA; Borchin R; Krischer JP; Merkel PA;
    Trials; 2020 Apr; 21(1):362. PubMed ID: 32345372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous granulomatous vasculitis associated with chronic lymphocytic leukemia: case report and review of literature of a rare entity.
    Gaertner EM; Switlyk SA
    Dermatol Online J; 2012 Mar; 18(3):12. PubMed ID: 22483523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical approach to the vasculitis patient in the dermatologic office.
    Callen JP
    Clin Dermatol; 1999; 17(5):549-53. PubMed ID: 10590847
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    Holtman JH; Neustadt DH; Klein J; Callen JP
    J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vasculitis.
    Fiorentino DF
    J Am Acad Dermatol; 2003 Mar; 48(3):311-40. PubMed ID: 12637912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans' cells and cutaneous necrotizing vasculitis.
    Lotti TM; Ghersetich I; Comacchi C; Katsambas A; Tsoureli E
    Clin Dermatol; 1999; 17(5):591-6. PubMed ID: 10590855
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of refractory eosinophilic fasciitis with eosinophilic vasculitis.
    Minami S; Fujimoto N; Takahashi T; Nakanishi T; Tanaka T
    Eur J Dermatol; 2016 Jun; 26(3):319-20. PubMed ID: 27033137
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular steps in pathogenesis of cutaneous necrotizing vasculitis.
    Ghersetich I; Comacchi C; Katsambas A; Lotti TM
    Clin Dermatol; 1999; 17(5):597-601. PubMed ID: 10590856
    [No Abstract]   [Full Text] [Related]  

  • 20. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.